Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 2;121(8):e20230767.
doi: 10.36660/abc.20230767. eCollection 2024.

Pathogenesis, Assessment, and Treatment of Coronary Microcirculation Dysfunction

[Article in Portuguese, English]
Bing Ji  1 , Xue-Bo Liu  2
Affiliations
Review

Pathogenesis, Assessment, and Treatment of Coronary Microcirculation Dysfunction

[Article in Portuguese, English]
Bing Ji et al. Arq Bras Cardiol. .

Abstract
in English, Portuguese

Cardiovascular disease is the predominant cause of mortality on a global scale. Research indicates that women exhibit a greater likelihood of presenting with non-obstructive coronary artery disease (CAD) when experiencing symptoms of myocardial ischemia in comparison to men. Additionally, women tend to experience a higher burden of symptoms relative to men, and despite the presence of ischemic heart disease, they are frequently reassured erroneously due to the absence of obstructive CAD. In cases of ischemic heart disease accompanied by symptoms of myocardial ischemia but lacking obstructive CAD, it is imperative to consider coronary microvascular dysfunction as a potential underlying cause. Coronary microvascular dysfunction, characterized by impaired coronary flow reserve resulting from functional and/or structural abnormalities in the microcirculation, is linked to adverse cardiovascular outcomes. Lifestyle modifications and the use of anti-atherosclerotic and anti-anginal medications may offer potential benefits, although further clinical trials are necessary to inform treatment strategies. This review aims to explore the prevalence, underlying mechanisms, diagnostic approaches, and therapeutic interventions for coronary microvascular dysfunction.

A doença cardiovascular é a causa predominante de mortalidade em escala global. A pesquisa indica que as mulheres, em comparação aos homens, apresentam maior probabilidade de apresentar doença arterial coronariana (DAC) não obstrutiva quando têm sintomas de isquemia miocárdica. Além disso, as mulheres tendem a apresentar uma maior carga de sintomas em relação aos homens e, apesar da presença de doença cardíaca isquêmica, são frequentemente tranquilizadas erroneamente devido à ausência de DAC obstrutiva. Nos casos de cardiopatia isquêmica acompanhada de sintomas de isquemia miocárdica, mas sem DAC obstrutiva, é imperativo considerar a disfunção microvascular coronariana como uma potencial causa subjacente. A disfunção microvascular coronariana, caracterizada por reserva de fluxo coronariano prejudicada resultante de anormalidades funcionais e/ou estruturais na microcirculação, está associada a desfechos cardiovasculares adversos. Modificações no estilo de vida e o uso de medicamentos antiateroscleróticos e antianginosos podem oferecer benefícios potenciais, embora sejam necessários mais ensaios clínicos para informar estratégias de tratamento. Esta revisão tem como objetivo explorar a prevalência, mecanismos subjacentes, abordagens diagnósticas e intervenções terapêuticas para disfunção microvascular coronariana.

PubMed Disclaimer

Conflict of interest statement

Potencial conflito de interesse

Não há conflito com o presente artigo

References

    1. Sara JD, Widmer RJ, Matsuzawa Y, Lennon RJ, Lerman LO, Lerman A. Prevalence of Coronary Microvascular Dysfunction among Patients with Chest Pain and Nonobstructive Coronary Artery Disease. JACC Cardiovasc Interv. 2015;8(11):1445–1453. doi: 10.1016/j.jcin.2015.06.017. - DOI - PubMed
    1. Aribas E, van Lennep JER, Elias-Smale SE, Piek JJ, Roos M, Ahmadizar F, et al. Prevalence of Microvascular Angina among Patients with Stable Symptoms in the Absence of Obstructive Coronary Artery Disease: A Systematic Review. Cardiovasc Res. 2022;118(3):763–771. doi: 10.1093/cvr/cvab061. - DOI - PMC - PubMed
    1. Jones E, Eteiba W, Merz NB. Cardiac Syndrome X and Microvascular Coronary Dysfunction. Trends Cardiovasc Med. 2012;22(6):161–168. doi: 10.1016/j.tcm.2012.07.014. - DOI - PMC - PubMed
    1. Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J, et al. Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes. Circulation. 2014;129(24):2518–2527. doi: 10.1161/CIRCULATIONAHA.113.008507. - DOI - PMC - PubMed
    1. Camici PG, Crea F. Coronary Microvascular Dysfunction. N Engl J Med. 2007;356(8):830–840. doi: 10.1056/NEJMra061889. - DOI - PubMed